Table 1: Demographic and pre injection IVO clinical characteristics of patients.

n	Age years	Gender f: female m: male	Eye r: right l: left	Lens p: phakic pp: pseudophakic ap: aphakic	Duration time months	Anti-inflammatory topical therapy
1	62	f	r	pp	3	steroid
2	58	m	r	p	4	--
3	89	m	l	pp	45	bromfenac
4	89	m	r	pp	45	bromfenac
5	65	m	r	p	12	prednisolone acetate ophthalmic suspension (steroid)
6	76	f	r	pp	7	nepafenac ophthalmic suspension (NSAID)
7	77	m	l	pp	4	indometacine
descriptive analysis	Mean 73.71 ± 2.53 range 58 -89	2 (28.6%) f 5 (71.4%) m	5(71.4%) r 2 (28.6%) l	2 (28.6%) p 571.4(%) pp	Mean 17.14 ± 19.26 range 3 - 45	2 (28.6%) steroids 2 (28.6%) bromfenac 1 (14.3%) nepafanac 1 (14.3%) indometacine 1 (14.3%) ---